Corpus Intelligence IC Memo — LINDEN OAKS HOSPITAL 2026-04-26 14:21 UTC
IC Memo — LINDEN OAKS HOSPITAL
Investment Committee Memorandum | IL | 110 beds | Grade C | EBITDA uplift $1.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

LINDEN OAKS HOSPITAL

CCN 144035 | DUPAGE, IL | 110 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

LINDEN OAKS HOSPITAL is a 110-bed under-performing / distressed in DUPAGE, IL with $25.8M in net patient revenue and a -30.8% operating margin. The hospital serves a payer mix of 12.2% Medicare, 1.4% Medicaid, and 86.4% commercial.

Thesis: Undervalued. Our ML models identify $1.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -30.8% to -23.4% (+736bps).

Net Revenue HCRIS$25.8M
Current EBITDA COMPUTED$-7.9M
Operating Margin COMPUTED-30.8%
Occupancy HCRIS57.4%
Revenue / Bed COMPUTED$235K
Net-to-Gross HCRIS42.0%
Distress Probability ML47.9%

2. Market Context & Competitive Position

208
IL Hospitals
-5.3%
State Median Margin
81
Comparable Hospitals

IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of -30.8% places it below the state median. Among 81 size-comparable peers (55-220 beds), the median margin is -7.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (55-220), prioritizing same-state peers. 81 hospitals in the comp set.

HospitalStateBedsRevenueMargin
LINDEN OAKS HOSPITAL (Target)IL110$25.8M-30.8%
MIDWESTERN REGIONAL MEDICAL CEIL73$1.38B80.5%
NORTHWESTERN LAKE FOREST HOSPIIL124$494.3M-13.8%
SARAH BUSH LINCOLN HEALTH CENTIL100$448.6M-18.1%
DELNOR-COMMUNITY HOSPITALIL149$441.4M6.4%
METHODIST MEDICAL CTR OF ILLINIL203$381.6M-7.8%
GOOD SHEPHERD HOSPITALIL176$375.2M20.0%
JAVON BEA HOSPITALIL194$364.4M10.0%
SWEDISH COVENANT HEALTHIL173$363.5M-3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$542K+210bp18mo
Cost to Collect4.5%2.5%$516K+200bp12mo
Denial Rate Reduction12.0%6.5%$511K+198bp12mo
A/R Days Reduction5200.0%3800.0%$314K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$542K
Cost to Collect
$516K
Denial Rate Reduction
$511K
A/R Days Reduction
$314K
Clean Claim Rate
$17K
Total EBITDA Uplift$1.9M
Current EBITDA$-7.9M
+ RCM Uplift+$1.9M
Pro Forma EBITDA$-6.0M
Current Margin-30.8%
Pro Forma Margin-23.4%
WC Released (1x)$990K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-12.2M$-33.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-12.2M$-40.7M0.00x-100.0%
Bull Case9.0x11.0x$-11.0M$-38.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.0M$-45.1M0.00x-100.0%
Bear Case11.0x10.0x$-13.4M$-38.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-13.4M$-47.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 81 hospitals with 55-220 beds
  • Same-state prioritization (n=82)
  • Comp margins: P25=-20.6% / P50=-7.7% / P75=6.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.